Monotherapy with metformin: Does it improve hypoxia in type 2 diabetic patients?

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 9, 2001, Pages 818-821

  Cosic V ^a   Antic S ^a   Pesic M ^a   Jovanovic O ^a   Kundalic S ^a   Djordjevic V B ^a  

^a Centar za Medicinsku Biohemiju ^*  (Serbia)

Author keywords

Diabetes; Glutathione peroxidase; Hypoxia; Lipid peroxidation; Metformin; Xanthine oxidase

Indexed keywords

ANTIOXIDANT; ERYTHROCYTE ENZYME; FREE RADICAL; FRUCTOSAMINE; GLUTATHIONE PEROXIDASE; LACTIC ACID; METFORMIN; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FRUCTOSAMINE BLOOD LEVEL; HUMAN; HYPOXIA; LACTATE BLOOD LEVEL; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0034813089     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.135     Document Type: Article

References (26)

1. Effect of repaglinide addition on patients with type 2 diabetes
2. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus
3. UK Prospective Diabetes Study 24: Relative efficacy of sulfonylurea, insulin and metformin therapy in newly diagnosed non-insulin dependent diabetes with primary diet failure followed for six years
4. UK Prospective Diabetes Study 34: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes
5. The effect of metformin on insulin receptors and lipid peroxidation in alloxan and streptozotocin induced diabetes
6. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production
7. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups
8. The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-triphosphate mass in Xenopus oocytes
9. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor α-submit
10. Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin
11. Metabolic control quality and free radical activity in diabetic patients
12. Hydroxyl radical production and autooxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing
13. Glycation of proteins as a source of superoxide
14. Oxidative damage of vascular smooth muscle cells by the glycated protein-cupric ion system
15. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation
16. Metformin reduces systemic methylglyoxal levels in type 2 diabetes
17. Oxidative stress and insulin action: Is there a relationship?
18. Ohygen, ischemia and inflamation
19. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue
20. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
21. Simple micro-assay methods for enzymes of purine metabolism
22. A modified thiobarbituric acid test for measuring lipid peroxidation
23. Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control
24. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defence enzymes in newly diagnosed obese patients with type 2 diabetes
25. Xanthine oxidase: Biochemistry, distribution and physiology